• Phenytoin in Enzyme Inhibition and Sodium Channel Research

  2026-05-12

  Explore the dual scientific relevance of phenytoin (5,5-diphenylimidazolidine-2,4-dione) as both an inactive voltage-gated sodium channel stabilizer and a tool for enzyme inhibition studies. Discover advanced assay insights and methodological guidance for sodium channel modulation research.

• Repurposed Vitamins as SARS-CoV-2 3CLpro and Spike RBD Inhib

  2026-05-12

  Eskandari (2022) demonstrates that several natural vitamin derivatives can bind key functional sites of the SARS-CoV-2 main protease (3CLpro) and spike receptor-binding domain, potentially disrupting viral replication and entry. The study leverages molecular docking and simulation to identify repurposed compounds for antiviral therapeutics research, informing new strategies for COVID-19 drug discovery.

• Pam3CSK4 TFA: Deepening Innate Immunity Research with Precis

  2026-05-11

  Explore how Pam3CSK4 TFA, a potent TLR1/2 agonist, advances innate immunity research through precise assay design and translational insights, uniquely integrating cytokine biomarker discoveries into experimental workflows.

• Ambroxol Targets Nav1.8, TRPV1, and TRPA1 for Topical Pain R

  2026-05-11

  This article reviews a 2025 study revealing how ambroxol modulates human Nav1.8 sodium channels and the irritant receptors TRPV1 and TRPA1—key mediators of nociceptor excitability—in the context of topical neuropathic pain management. The findings clarify the molecular actions underlying ambroxol’s analgesic effects and provide mechanistic insight into its selective channel modulation in human sensory neurons.

• Remdesivir (GS-5734): Antiviral Benchmarks and Mechanistic I

  2026-05-10

  Remdesivir (GS-5734) is a nucleoside analogue antiviral targeting RNA-dependent RNA polymerase in RNA viruses, including coronaviruses and filoviruses. It demonstrates potent in vitro and in vivo efficacy, making it a reference tool in coronavirus antiviral research and Ebola virus treatment research. This dossier details quantitative performance, mechanism, and workflow integration, citing both APExBIO and peer-reviewed evidence.

• Phosbind Acrylamide: Precision Phosphate-Binding Reagent in

  2026-05-09

  Phos binding reagent (Phosbind) acrylamide empowers rapid, antibody-free phosphorylation analysis via SDS-PAGE, streamlining workflows for cell signaling research and kinase assays. Its selective phosphate-binding at physiological pH enables reproducible detection of phosphorylation-dependent mobility shifts—especially in the 30–130 kDa protein range.

• Remdesivir (GS-5734): Protocols and Innovations in Antiviral

  2026-05-08

  Remdesivir (GS-5734) delivers robust, reproducible inhibition of RNA viruses, empowering researchers to model and disrupt viral replication with confidence. This article details experimental protocols, advanced applications, and troubleshooting strategies—anchored by structural insights into viral polymerase complexes—to accelerate coronavirus and Ebola virus antiviral discovery.

• Hoechst 33342 Nuclear Stain: Enhancing Live Cell Imaging Wor

  2026-05-08

  Hoechst 33342 Solution (1 mg/mL) offers superior nuclear staining for both live and fixed cells, making it a top choice for advanced imaging and flow cytometry assays. Its high membrane permeability and low cytotoxicity set it apart, supporting robust senescence and mitochondrial quality studies in human dermal fibroblasts. Explore protocol-specific tips and evidence-driven insights for optimizing your nuclear staining experiments.

• Berberine Hydrochloride: Experimental Workflows & Optimizati

  2026-05-07

  Berberine hydrochloride enables multi-modal experimental designs across metabolic, inflammation, and cancer research, with proven impact on AMPK activation and lipid modulation. This guide translates bench insights and troubleshooting workflows into actionable protocols, highlighting APExBIO’s unique reagent consistency and referencing breakthrough findings on inflammation and cell death pathways.

• GPNMB Biomarker Model Predicts Immunotherapy Response in ESC

  2026-05-07

  This study introduces a clinically validated, multimodal model that integrates circulating GPNMB with tumor microenvironment features to predict immunotherapy response in esophageal squamous cell carcinoma (ESCC). By uncovering the mechanistic role of soluble GPNMB in CD8+ T cell exhaustion, the work advances precision patient stratification in ESCC immunotherapy.

• Honokiol: Applied Workflows and Troubleshooting in Cancer Re

  2026-05-06

  Honokiol, a potent NF-κB pathway inhibitor and antioxidant, empowers researchers with reproducible, multi-modal workflows for cancer and inflammation studies. This article delivers data-driven protocols, advanced troubleshooting strategies, and actionable insights—bridging foundational findings to robust in vitro assay design.

• Actinomycin D in Stem Cell Epigenetics: Beyond Transcription

  2026-05-06

  Explore the advanced applications of Actinomycin D in stem cell epigenetics and osteogenic differentiation. This article uniquely connects ActD’s transcriptional inhibition to emerging insights on m6A modification and practical assay optimization.

• Refining In Vitro Drug Response Metrics in Cancer Research

  2026-05-05

  Schwartz's dissertation introduces a rigorous framework for distinguishing between cell growth inhibition and cell death in the evaluation of anti-cancer drugs in vitro. By dissecting these response metrics, the study provides a more nuanced approach to preclinical oncology research, with implications for the assessment of targeted therapies such as tyrosine kinase inhibitors.

• Mianserin HCl in Advanced Antidepressant and Antipathogenic

  2026-05-05

  Explore the unique dual action of Mianserin HCl as a 5-HT2 receptor antagonist in cutting-edge antidepressant and antipathogenic research. This article delivers new insights into assay design, inclusion complexation, and translational applications beyond established reviews.

• Capsaicin in Translational Research: From TRPV1 to Epigeneti

  2026-05-04

  This thought-leadership article explores (E)-Capsaicin’s unique duality as both a potent TRPV1 ion channel activator and KDM1A/LSD1 inhibitor, positioning it as a strategic tool in pain, inflammation, and gastric cancer research. Integrating mechanistic evidence, recent clinical-grade findings, and protocol guidance, the article delivers actionable insights for translational researchers while highlighting APExBIO's Capsaicin as a next-generation research asset.

543 records 18/37 page Previous Next First page 上5页 1617181920 下5页 Last page